These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30554541)

  • 21. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
    Lebwohl M; Colón LE
    Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER).
    Lambert J; Ghislain PD; Lambert J; Cauwe B; Van den Enden M
    J Dermatolog Treat; 2017 Aug; 28(5):394-400. PubMed ID: 27791446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
    Jensen JD; Delcambre MR; Nguyen G; Sami N
    Am J Clin Dermatol; 2014 Oct; 15(5):379-85. PubMed ID: 25027461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of Common Psoriasis Medications, 2010-2014.
    James SM; Hill DE; Feldman SR
    J Drugs Dermatol; 2016 Mar; 15(3):305-8. PubMed ID: 26954315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review.
    Tada Y; Komine M; Okubo Y; Habiro K; Tsuritani K; Morita A
    J Dermatol; 2024 Feb; 51(2):210-222. PubMed ID: 38031882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
    Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
    Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
    van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Per-gram cost of medication is by itself a poor indicator for comparing costs of different psoriasis treatments: a retrospective cohort study of the cost of psoriasis treatment with topical corticosteroids versus topical calcipotriene.
    Feldman SR; Sahu S; Fleischer AB; Dezii CM
    J Cutan Med Surg; 2000 Jul; 4(3):121-5. PubMed ID: 11003715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ORBIT (Outcome and Retention Rate of Biologic Treatments for Psoriasis): A retrospective observational study on biologic drug survival in daily practice.
    Vilarrasa E; Notario J; Bordas X; López-Ferrer A; Gich IJ; Puig L
    J Am Acad Dermatol; 2016 Jun; 74(6):1066-72. PubMed ID: 27004803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of Topical Use in Psoriasis Patients in the REFINE Study.
    Gooderham MJ; Poulin-Costello M; Shelton J; Bayan N; Papp KA
    J Cutan Med Surg; 2016; 20(2):106-12. PubMed ID: 26330052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Retrospective Review of Patients' Response to Biologic Therapy for Psoriasis.
    Bagel J; Butler B; Nelson E; Hetzel A
    J Drugs Dermatol; 2021 Apr; 20(4):442-449. PubMed ID: 33852233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasis treatment patterns: a retrospective claims study.
    Higa S; Devine B; Patel V; Baradaran S; Wang D; Bansal A
    Curr Med Res Opin; 2019 Oct; 35(10):1727-1733. PubMed ID: 31081697
    [No Abstract]   [Full Text] [Related]  

  • 33. A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy.
    Bagel J; Zapata J; Nelson E
    J Drugs Dermatol; 2018 Aug; 17(8):845-850. PubMed ID: 30124723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combining biologic therapies with other systemic treatments in psoriasis: evidence-based, best-practice recommendations from the Medical Board of the National Psoriasis Foundation.
    Armstrong AW; Bagel J; Van Voorhees AS; Robertson AD; Yamauchi PS
    JAMA Dermatol; 2015 Apr; 151(4):432-8. PubMed ID: 25517130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes associated with the use of biologic agents in moderate to severe psoriasis.
    Price J; Bhosle M; Feldman SR; Balkrishnan R
    J Drugs Dermatol; 2007 Mar; 6(3):259-67. PubMed ID: 17373187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity.
    Murage MJ; Anderson A; Oliveria SA; Casso D; Ojeh CK; Muram TM; Merola JF; Araujo AB
    J Med Econ; 2018 Aug; 21(8):745-754. PubMed ID: 29718756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction: A Collaborative Analysis Using International Cohorts.
    Gulliver WP; Young HM; Bachelez H; Randell S; Gulliver S; Al-Mutairi N
    J Cutan Med Surg; 2016 Nov; 20(6):550-554. PubMed ID: 27402717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment patterns among patients with psoriasis using a large national payer database in the United States: a retrospective study.
    Murage MJ; Kern DM; Chang L; Sonawane K; Malatestinic WN; Quimbo RA; Feldman SR; Muram TM; Araujo AB
    J Med Econ; 2018 Oct; ():1-9. PubMed ID: 30358465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain.
    Notario J; Deza G; Vilarrasa E; Valentí F; Muñoz C; Mollet J; Rocamora V; Carrascosa JM; Del Alcázar E; Alsina M; Vidal D; Puig L; López-Ferrer A; Riera J; Gallardo F; Ferran M
    J Dermatolog Treat; 2019 Aug; 30(5):424-429. PubMed ID: 30244618
    [No Abstract]   [Full Text] [Related]  

  • 40. Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis.
    Armstrong A; Levi E
    J Drugs Dermatol; 2017 Dec; 16(12):1240-1245. PubMed ID: 29240859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.